Geographic · Property, plant and equipment, net

Europe — Property, plant and equipment, net

Moderna Europe — Property, plant and equipment, net increased by 7.1% to $303.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $283.00M to $303.00M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2025Feb 20, 2026
Rolls up toPP&E (Net)

How to read this metric

An increase suggests capital expansion or investment in local production capacity, while a decrease may signal asset depreciation, divestment, or a shift toward outsourcing.

Detailed definition

This metric represents the net book value of tangible long-term assets located within the European segment, including ma...

Peer comparison

Comparable to regional asset disclosures in 10-K filings for global life sciences companies, reflecting the scale of regional supply chain and R&D infrastructure.

Metric ID: mrna_segment_europe_property_plant_and_equipment_net

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$181.00M$714.00M$126.00M$283.00M$303.00M
QoQ Change+294.5%-82.4%+124.6%+7.1%
YoY Change+294.5%-82.4%+124.6%+7.1%
Range$126.00M$714.00M
CAGR+67.4%
Avg YoY Growth+85.9%
Median YoY Growth+65.8%
Current Streak2 quarters growth

Frequently Asked Questions

What is Moderna's europe — property, plant and equipment, net?
Moderna (MRNA) reported europe — property, plant and equipment, net of $303.00M in Q4 2025.
How has Moderna's europe — property, plant and equipment, net changed year-over-year?
Moderna's europe — property, plant and equipment, net increased by 7.1% year-over-year, from $283.00M to $303.00M.
What does europe — property, plant and equipment, net mean?
The net value of the company's physical assets and infrastructure located in Europe.